These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26936391)

  • 1. Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.
    Chen Y; Shi J
    Adv Mater; 2016 May; 28(17):3235-72. PubMed ID: 26936391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics.
    Cheng Y; Jiao X; Fan W; Yang Z; Wen Y; Chen X
    Biomaterials; 2020 Oct; 256():120191. PubMed ID: 32593907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile synthesis of mesoporous organosilica nanobowls with bridged silsesquioxane framework by one-pot growth and dissolution mechanism.
    Du X; Li W; Shi B; Su L; Li X; Huang H; Wen Y; Zhang X
    J Colloid Interface Sci; 2018 Oct; 528():379-388. PubMed ID: 29870824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mesoporous organosilica nanoparticles with ferrocene group for efficient removal of contaminants from wastewater.
    Yang S; Chen S; Fan J; Shang T; Huang D; Li G
    J Colloid Interface Sci; 2019 Oct; 554():565-571. PubMed ID: 31326788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organosilica Nanoparticles and Medical Imaging.
    Nakamura M
    Enzymes; 2018; 44():137-173. PubMed ID: 30360813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous Organosilica Hollow Nanoparticles: Synthesis and Applications.
    Teng Z; Li W; Tang Y; Elzatahry A; Lu G; Zhao D
    Adv Mater; 2019 Sep; 31(38):e1707612. PubMed ID: 30285290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
    Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
    Croissant JG; Fatieiev Y; Almalik A; Khashab NM
    Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of stimuli-responsive mesoporous organosilica nanocarriers for drug delivery.
    Guimarães RS; Rodrigues CF; Moreira AF; Correia IJ
    Pharmacol Res; 2020 May; 155():104742. PubMed ID: 32151682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic-inorganic hybrid mesoporous silicas: functionalization, pore size, and morphology control.
    Park SS; Ha CS
    Chem Rec; 2006; 6(1):32-42. PubMed ID: 16470802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality.
    Huang P; Chen Y; Lin H; Yu L; Zhang L; Wang L; Zhu Y; Shi J
    Biomaterials; 2017 May; 125():23-37. PubMed ID: 28226244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous materials: tunable structure, morphology and composition.
    Yang Z; Lu Y; Yang Z
    Chem Commun (Camb); 2009 May; (17):2270-7. PubMed ID: 19377657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured hybrid materials from aqueous polymer dispersions.
    Castelvetro V; De Vita C
    Adv Colloid Interface Sci; 2004 May; 108-109():167-85. PubMed ID: 15072940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Degradable Mesoporous Organosilica-Based Nanomaterials for Controlling Drug Delivery: A Mini Review.
    Poscher V; Salinas Y
    Materials (Basel); 2020 Aug; 13(17):. PubMed ID: 32825140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Facile Multi-interface Transformation Approach to Monodisperse Multiple-Shelled Periodic Mesoporous Organosilica Hollow Spheres.
    Teng Z; Su X; Zheng Y; Zhang J; Liu Y; Wang S; Wu J; Chen G; Wang J; Zhao D; Lu G
    J Am Chem Soc; 2015 Jun; 137(24):7935-44. PubMed ID: 26030506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous Metal-Organic Frameworks: Synthetic Strategies and Emerging Applications.
    Liu D; Zou D; Zhu H; Zhang J
    Small; 2018 Sep; 14(37):e1801454. PubMed ID: 30073756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.